SUVEN LIFE SCIENCES
|
The Current P/S Ratio of SUVEN LIFE SCIENCES is 1,035.34.
| Share Price | ₹279.4 | May 29,2026 |
| Market Cap | ₹7,366.5 Cr | |
| Sales-TTM | ₹7.1 Cr | TTM-Consolidated Results |
| Price/Sales | 1,035.34x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SUVEN LIFE SCIENCES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹7,366.5 Cr] as on May 29,2026
(/) Sales [ ₹7.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1,035.34x ]
Thus, for SUVEN LIFE SCIENCES , the investors are currently willing to pay '1,035.34 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUVEN LIFE SCIENCES !
The chart below summarizes the trend in P/S Ratio of SUVEN LIFE SCIENCES over the last five years.
Historical PS (Price/Sales) ratio chart of SUVEN LIFE SCIENCES
PS Ratio Performance Analysis for SUVEN LIFE SCIENCES
- SUVEN LIFE SCIENCES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 163.18x.
- SUVEN LIFE SCIENCES 's operated at median p/e ratio of 113.85x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUVEN LIFE SCIENCES 's p/e ratio peaked in Mar2025 at 371.55x.
- SUVEN LIFE SCIENCES 's p/e ratio hit its five-year low in Mar2021 of 66.48x.
How does SUVEN LIFE SCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SUVEN LIFE SCIENCES | 7.1 | 1,035.34 | 7,366.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.39 | 432,096.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.74 | 176,807.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 10.64 | 148,718.0 |
| CIPLA LTD | 28,162.6 | 4.01 | 112,971.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.23 | 108,752.0 |
| MANKIND PHARMA LTD | 14,277.6 | 6.88 | 98,179.5 |
| LUPIN LTD | 27,958.0 | 3.72 | 103,900.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 3.99 | 108,442.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.45 | 82,330.8 |
| LAURUS LABS LTD | 6,812.9 | 10.79 | 73,506.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUVEN LIFE SCIENCES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.45x |
| Max industry PS | 1,035.34x |
| Median industry PS | 6.88x |
| Average industry PS | 100.47x |
You may also like the below Video Courses